![Radius Health, Inc. logo](/logos/RDUS.webp)
Radius Health, Inc.
NASDAQ:RDUS
Overview | Financials
Company Name | Radius Health, Inc. |
Symbol | RDUS |
Currency | USD |
Price | 14.68 |
Market Cap | 408,683,860 |
Dividend Yield | 3.85% |
52-week-range | 12.69 - 31.7 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Jesper Hoiland |
Website | https://radiuspharm.com |
An error occurred while fetching data.
About Radius Health, Inc.
Radius Health, Inc., a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD